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Abstract: 
Study design: Literature review. 
Objectives: Spinal cord injury (SCI) remains a major public health issue in developed countries 
as well as worldwide. The pathophysiology of SCI is characterized by an initial primary injury 
followed by secondary deterioration. Although the etiology and pathogenesis of SCI remain to be 
fully understood, it has been suggested that reactive oxygen species (ROS) and oxidative stress 
have a significant role in the pathophysiology of SCI. Thus, alleviating oxidative stress may be 
an effective strategy for therapeutic intervention of SCI. The aim of this review was to describe 
(i) the sources of ROS as well as the major antioxidant defenses with particular attention being 
paid to lipid peroxidation; (ii) the biomarkers of oxidative stress in SCI and (iii) the 
neuroprotective effects of various compounds with antioxidative properties in animal models of 
SCI.  
Methods: PubMed, one of the most comprehensive biomedical databases, was searched from 
1976–2011. All relevant papers were read by title, abstract and full-length article. 
Results: Oxidative stress is considered a hallmark of injury of SCI. Thus, alleviating oxidative 
stress may be an effective way of therapeutic intervention of SCI. Two of these agents, the 
glucocorticoid steroid methylprednisolone and the non-glucocorticoid 21-aminosteroid tirilazad, 
have been shown to possess significant antioxidant activities and improve recovery of SCI 
patients in clinical trials. Other promising botanical compounds and their molecular targets and 
mechanisms of action with regard to potential protection against SCI were also described. These 
include carotenoids and phenolic compounds. 
Conclusion: ROS and oxidative stress have a significant role in the pathophysiology of SCI. 
Alleviating oxidative stress is be an effective strategy for therapeutic intervention of SCI. 
Extensive research over the past several decades has identified numerous bioactive compounds 
that have antioxidative stress benefits in animal models of SCI. Thus, continued studies on 
bioactive compounds with ROS-scavenging capacity may lead to the development of effective 
antioxidant-based modalities for treating SCI in human subjects. 
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Article: 
INTRODUCTION 
Spinal Cord injury (SCI) is damage or trauma to the spinal cord resulting in paralysis and loss of 
sensation. There are B400 000 spinally injured patients in the United States with over 14 000 
new injuries occurring each year.1 SCI imposes high physical and psychological effects not only 
to the individual, but also to the family and the society. Depending on the location of the injury, 
the symptoms of SCI may include loss of movement, sensation to feel heat, cold and touch, loss 
of bowel or bladder control and exaggerated reflex activities as well as pain.1 
The pathophysiology of SCI is characterized by an initial primary injury followed by a secondary 
phase of injury in which oxidative stress is a critical component. Primary injury results 
immediately from the initial trauma, which includes contusion, damage to blood vessels and 
axonal shearing. In contrast, secondary injury is an indirect result from primary injury initiated 
by trauma. It occurs in hours, days and weeks following the primary injury. Secondary injury 
occurs not only at the site of the initial primary injury, but also results in spreading of the lesion 
to adjacent, otherwise uninjured tissue. Because secondary injury to spinal cord has an important 
role in disease progression, it is important to understand the molecular and cellular events 
leading to the secondary lesion of SCI. 
Although the etiology and pathogenesis of SCI remain to be further elucidated, extensive studies 
over the last two decades have suggested that increased formation of reactive oxygen species 
(ROS) and the consequent oxidative stress are important events associated with SCI. The 
neurons and glia in the central nervous system including spinal cord are particularly prone to 
oxidative and electrophilic stress due to many factors, including a high content of 
polyunsaturated fatty acids, a high rate of oxidative metabolic activity, intense production of 
reactive oxygen metabolites and relatively low antioxidant capacity.2,3 Indeed, oxidative stress is 
considered a hallmark of the secondary phase of injury of SCI.2,3 Thus, alleviating oxidative 
stress may be an effective way of therapeutic intervention of SCI. 
METHODS 
We searched MEDLINE (PubMed) and reference lists of the included articles published mainly 
between 1976 and 2011 using the following key words: SCI, oxidative stress, biomarkers, 
antioxidant, bioactive compounds and intervention.  
RESULTS 
ROS and oxidative stress in SCI 
Reactive oxygen species (ROS). Molecular oxygen is an essential element of life, yet incomplete 
reduction or excitation of oxygen during aerobic metabolism generates ROS. ROS include 
superoxide, hydroxyl radical, singlet oxygen and hydrogen peroxide (Figure 1). Superoxide is 
the one-electron reduction product of molecular oxygen. If two electrons are transferred, the 
product is hydrogen peroxide. Transition metal ions, such as Fe2+ or Cu+ are capable of 
transferring a third electron to hydrogen peroxide, causing lysis of the O–O bond generating the 
hydroxyl radical, one of the most potent oxidants known. In phagocytes, superoxide is produced 
in large quantities by the enzyme nicotinamide adenine dinucleotide phosphate oxidase for use in 
oxygen-dependent killing mechanisms.4 Superoxide has also been implicated in the mechanisms 
of aging and the peroxidation of lipids. Hydrogen peroxide is not a free radical but is nonetheless 
a damaging species because of its ability to penetrate biological membranes. Hydrogen peroxide 
is toxic to cells and can lead to further free-radical generation. For example, hydrogen peroxide 
reacts with reduced transition metals to form the highly reactive hydroxyl radical, which readily 
causes damage to DNA and other biological molecules.5–7 Previous studies have demonstrated 
that the formation of ROS including hydroxyl radical, superoxide and hydrogen peroxide 
immediately after central nervous system injury may contribute to the pathogenesis of SCI.8,9 
Source of ROS. Production of ROS under physiological conditions is important for normal 
cellular redox reactions. However, excessive generation of free radicals under pathophysiological 
conditions such as SCI can greatly enhance the production of ROS. Mitochondrias are the major 
source of cellular ROS because they consume about 90% of the oxygen utilized by cells during 
the oxidative phosphorylation under physiological conditions. The mitochondrial dysfunction 
results in further increased formation of ROS. Structural and functional alterations of the 
mitochondria have been found in a SCI mouse model.10 SCI results in a cascade of secondary 
events including release of excitatory amino acids and disruption of calcium homeostasis, which 
may further cause the mitochondrial dysfunction and augmented ROS formation, leading to 
neuronal cell death.2 In addition to the mitochondria, phagocytic cells such as neutrophils and 
macrophages also contribute to the generation of ROS following experimental SCI.4 After 
traumatic SCI, phagocytic cells exhibit a marked increase in oxygen consumption and generation 
of superoxide from membranes associated nicotinamide adenine dinucleotide phosphate oxidase. 
The enzyme complex transfers electrons from nicotinamide adenine dinucleotide phosphate 
oxidase at the cytosolic side of the membrane to molecular oxygen at the other side of the 
membrane resulting in the production of extracellular superoxide.4 Other potential biological 
sources of ROS associated with the pathogenesis of traumatic SCI include soluble cell 
constituents, cytosolic oxidases, transition metals, lysosomes, peroxisomes and endoplasmic 
reticulum. For example, there are many cytosolic enzymes that can generate ROS via reduction 
of molecular oxygen in their catalytic cycles. The most notable one is xanthine oxidase, which 
can directly reduce molecular oxygen to superoxide and hydrogen peroxide.11  
 
Figure 1. Schematic illustration of the formation of reactive oxygen species 
Antioxidant defenses. ROS participate in physiological processes, such as cell signaling. 
However, excessive generation of ROS under pathophysiological conditions, including SCI may 
result in oxidative stress. To control ROS, aerobic organism has utilized several antioxidative 
mechanisms including enzymatic and non-enzymatic antioxidants12 (Figure 2). Non-enzyme low 
molecular weight antioxidant compounds include cellular glutathione, vitamins C and E, β-
carotene and uric acid. The antioxidant enzymes include superoxide dismutase (SOD), catalase, 
glutathione reductase and glutathione peroxidase among others. SOD catalyzes the dismutation 
of superoxide to H2O2 in the following reaction: O2 + O2•− + 2H+-H2O2+O2. Mammalian cells 
contain three forms of SOD, MnSOD, Cu,ZnSOD and extracellular SOD. MnSOD is most 
abundant in the mitochondria, whereas Cn,ZnSOD predominant in the cytoplasm.13 Catalase is a 
major antioxidant enzyme that catalyzes the decomposition of H2O2 to H2O. Glutathione 
peroxidase is another major enzyme for decomposing H2O2.  
The elimination of ROS following SCI is particularly by cellular antioxidant glutathione and 
Cu,ZnSOD.14 Lucas, et al.14 examined the effects of glutathione treatment on lipid peroxidation 
after SCI in a rat contusion injury model. The results suggested that elevation of levels of 
glutathione by irrigation with δ-glutamylcysteine conferred significant protection against lipid 
peroxidation after SCI, suggesting that glutathione augmentation may be an effective strategy for 
curtailment of lipid peroxidation-mediated damage in SCI.14 Mutations in the gene for 
Cu,ZnSOD have been identified in familial amyotrophic lateral sclerosis (ALS), a disease 
characterized by damage and loss of neurons in both the brain and the spinal cord.15 Transgenic 
mice overexpressing wide-type Cu,ZnSOD gene show resistance to SCI, indicating that 
Cu,ZnSOD has an important role in protecting against spinal neuron death.16 
NAD(P)H:quinone oxidoreductase 1 (NQO1) is another important antioxidant enzyme that has 
recently been demonstrated to has a protective role in electrophilic stress underlying spinal cord 
damage.17,18 NQO1 catalyzes the two electron reduction of electrophilic quinone compounds, 
thus limiting the formation of semiquinone radicals through one electron reduction, and the 
subsequent generation of ROS.18,19 NQO1 is also able to maintain the cellular levels of 
ubiquinol and vitamin E, two important biological antioxidants involved in the detoxification of 
ROS.17,20 Therefore, the coordinated actions of a spectrum of cellular antioxidants and probably 
other cytoprotective proteins ensure efficient detoxification of ROS and electrophilic species that 
participate in the pathogenesis of SCI. 
 
Figure 2. ROS and their detoxification by cellular antioxidants. GPx, glutathione peroxidase; 
GR, glutathione reductase; GSH, reduced glutathione; GSSG, oxidized form of glutathione; 
GST, glutathione S-transferase; G6PDH, glucose-6-phosphate dehydrogenase; 6PGDH, 6-
phosphogluconate dehydrogenase; LOH, lipid alcohol; NQO1, NAD(P)H:quinone 
oxidoreductase 1; SOD, superoxide dismutase. 
Lipid peroxidation. High levels of ROS can overwhelm the normal cellular antioxidant defenses 
leading to several direct and indirect health effects. Direct effects include chain of peroxidation 
reactions involving lipids and other macromolecules. Indirect effects include modified metabolic 
pathways and altered pathophysiology of the organ systems due to the oxidative damage. 
Oxidative stress may occur when ROS are produced faster than they can be removed by cellular 
defense mechanisms. The main damage to cells results from ROS-induced alteration of 
macromolecules such as polyunsaturated fatty acids in membrane lipids, proteins, and DNA. 
Lipid peroxidation is a common and dangerous type of ROS-induced cellular oxidation. It has 
long been recognized that much of the posttraumatic degeneration of the spinal cord following 
injury is caused by a secondary injury process, and a significant biochemical event is ROS-
induced lipid peroxidation.2 In particular, spinal cord is highly vulnerable to oxidative injury 
owing to its overabundance of polyunsaturated fatty acids that are especially susceptible to 
peroxidation by ROS.3 The importance of ROS and lipid peroxidation in SCI is supported by 
many experimental and clinical studies demonstrating potential neural protective efficacy of 
multiple bioactive agents with antioxidant properties.2,21–26 
Nrf2 as a central regulator of antioxidant defenses. The coordinated elevation of antioxidant 
enzymes is regulated through a cis-acting element called the antioxidant response element (ARE) 
within the regulatory region of each of the antioxidant enzyme genes27,28 (Figure 3). 
Transcriptional activation mediated by the ARE is effected by the transcription factor Nrf2. Nrf2 
belongs to the CNC family of b-zip transcription factors. The mechanism by which binding of 
Nrf2 to ARE is induced is still emerging, but likely includes contributions from the repressor of 
Nrf2 that normally resides in the cytosolic compartment along with the cysteine-rich chaperone 
Keap1. Keap 1 is an inhibitor of Nrf2 that sequesters it in the cytoplasm. Activation of Nrf2 
dissociates Nrf2 from Keap1, allowing for its translocation to the nucleus, where it can interact 
with the ARE to activate transcription of antioxidant enzyme genes27,28 (Figure 3). Activation of 
Nrf2 and Nrf2-mediated antioxidant enzyme gene expression by pro-oxidants, including H2O2 at 
moderate non-lethal doses suggests that Nrf2 signaling may control the adaptive response of 
neuronal cells to oxidative insults.29 This potential Nrf2-mediated adaptive response to oxidative 
stress is particularly relevant to SCI where the increased level of ROS is constantly generated for 
a prolonged period of time leading to progressive oxidative stress in secondary injury of SCI.18 
Systematic increases in Nrf2 and ARE-driven heme oxygenase-1 in the spinal cord of SODG93A 
rats, an experimental model of ALS, have been reported,30,31 which may represent an adaptive 
response to oxidative stress. In view of the critical involvement of ROS in SCI, upregulation of 
ARE/Nrf2 pathway to augment endogenous antioxidant defenses may serve as a unique approach 
to protective/therapeutic intervention of SCI. 
Biomarkers of oxidative stress in SCI and their detection 
Biomarkers of ROS and oxidative stress are useful for assessing the pathogenesis and 
progression of SCI. Biomarkers are defined as characteristics that are objectively measured and 
evaluated as indicators of normal biological activities, pathogenic processes or pharmacological 
responses to therapeutic intervention. Because the highly reactive ROS are short lived and 
difficult to measure directly, indirect measures are most often used to predict the amount of ROS 
or the extent of oxidative stress occurring in SCI. These include the measurement of glutathione, 
Cu,ZnSOD, malondialdehyde (MDA), acrolein and F2-isoprostanes. It is of note that each 
marker has its own limitation in predicting oxidation in biological systems. As such, it is 
recommended that at least measurement of two markers should be used. 
Glutathione 
Glutathione is the primary low molecular weight thiol antioxidant and co-substrate for several 
cellular antioxidant enzymes such as glutathione peroxidase and and glutathione transferase. It 
has a critical role in maintaining the intracellular oxidation–reduction (redox) balance and 
regulating oxidative stress-induced signaling pathways as well as detoxifying ROS and other 
reactive aldehydes including acrolein.32 It is well known that the central nervous system 
including the spinal cord has relatively low glutathione levels compared with the other organs, 
such as the liver, which makes the neurons of the spinal cord especially vulnerable to oxidative 
stress.1,33–35 In the central nervous system, glutathione is present at high concentrations in the 
astrocytes, which also provide the substrate for glutathione synthesis such as cysteine and 
dipeptide cysteinyl-glycine to the neighboring neurons. In addition, it is reported that glutathione 
may also be an important regulatory neuropeptide in the central nervous system.36 
 
Figure 3. Nrf2 binds to the ARE and promotes transcription of antioxidant enzyme genes. 
The synthesis of glutathione from its constituent amino acids involves the actions of two ATP-
dependent enzymes, g-glutamylcysteine ligase (GCL) and glutathione synthase. GCL, the rate-
limiting enzyme in the overall pathway, is a heterodimer composed of a catalytic (GCLC) and a 
modulatory (GCLM) subunit. GCLC remains all the catalytic activity and GCLM improves the 
catalytic efficiency. It has been demonstrated that significant decreases in glutathione occurred in 
spinal segments T5–T9 with the greatest decrease seen at the site of injury and immediately 
adjacent segments. Between 24 and 48 h, significant decreases in glutathione were also observed 
throughout the spinal cord from spinal segments C3 to L4, suggesting that the decrease of 
glutathione may be a hallmark of oxidative stress that accompanies the prominent inflammatory 
changes after spinal cord trauma.37 
There are several chemical38 and enzymatic39 assays available for determination of glutathione. 
However, most of these assays lack sensitivity and specificity. Hissin and Hilf40 developed a 
fluorometric method for measuring glutathione. It is based on the reaction of reduced glutathione 
with o-phthalaldehyde to generate a highly fluorescent adduct that is specific for determination 
of reduced glutathione in rat tissue at pH 8.0.41 However, the original protocol developed by 
Hissin and Hilf requires a large amount of tissue samples. As such, it is not practical to routinely 
use the original protocol for glutathione determination in cultured neuronal cells especially under 
the conditions of using small volumes and microgram quantities of samples. We have modified 
the original method of Hissin and Hilf and reported a sensitive and specific assay for determining 
reduced glutathione status in human neuronal cells.42 The modified assay allows the use of small 
volumes and microgram quantities of samples, and is thus suitable for measuring reduced 
glutathione in a small number of cells. Given the use of a small sample volume, it also minimizes 
the presence of interfering substances in the samples. 
Cu,ZnSOD. As mentioned before, mammalian tissues contain three forms of SOD: cytosolic 
Cu,ZnSOD, mitochondrial MnSOD and extracellular SOD. The presence of SOD helps 
dismutate superoxide immediately upon its generation and thus protects cells from superoxide- 
mediated oxidative damage. Several point mutations in the gene that encodes Cu,ZnSOD have 
been reported in some patients with familial ALS, a disease that is characterized by a loss of 
motor neurons in both the brain and the spinal cord.43 The cytosolic SOD activity, which is 
primarily Cu,ZnSOD, was reduced by 38.8% in some familial ALS patients relative to the 
control subjects.43,44 Furthermore, overexpression of the Cu,ZnSOD mutants in rodents 
emulates clinical and pathological hallmarks of ALS through a possible mechanism of toxic gain 
of function.21 These results indicate a critical involvement of Cu,ZnSOD in neurodegeneration in 
ALS. Cellular Cu,ZnSOD activity can be measured using a commercially available kit from 
Trevigen, Inc. (Gaithersburg, MD, USA). This kit uses xanthine and xanthine oxidase to generate 
superoxide, which reacts with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride 
to form formazan blue, which is monitored at 560nm. The SOD activity is then determined by 
measuring the %inhibition of the reaction. 
Malondialdehyde (MDA). Lipid peroxidation is a well-defined mechanism of cellular damage 
and has been implicated in the pathogenesis of many disease processes including SCI. Lipid 
peroxidation is probably one of the most damaging effects of the ROS in SCI. Once a lipid 
radical is formed, polyunsaturated lipids can undergo self-propagating chains of peroxidation 
reactions. Aldehydes including MDA and the highly reactive a, b-unsaturated acrolein have been 
shown to be the end products of lipid peroxidation in SCI. There is increasing evidence 
suggesting that aldehydes may be causally involved in the pathophysiological effects associated 
with oxidative stress in SCI.45 
Thiobarbituric acid-reacting substance assay is frequently used for detecting MDA. The standard 
or sample to be tested is heated with thiobarbituric acid at low pH, and MDA reacts with 
thiobarbituric acid to produce a MDA-thiobarbituric acid colored complex. Absorbance of the 
pink chromogen is measured at 532nm or by fluorescence at 553nm. This assay measures both 
free MDA and protein-bound MDA. The MDA-586 method (Oxis International, Inc., Foster 
City, CA, USA) is designed to assay free MDA. The assay conditions serve to minimize 
interference from other lipid peroxidation products, such as 4-hydroxyalkenal. The principle of 
the MDA-586 method is based the reaction of a chromogenic reagent, N-methyl-2-phenylindone 
with MDA at 45 1C. One molecule of MDA reacts with 2 molecules of N-methyl-2-
phenylindone to yield a stable carbocyanine dye with maximum absorbance at 586nm. 
Acrolein. Acrolein, a major byproduct of oxidative stress and lipid peroxidation, has been 
implicated in the pathogenesis of SCI.3,46 As noted earlier, acrolein is a highly reactive a, b-
unsaturated aldehyde. It is produced as a byproduct of peroxidation of polyunsaturated fatty 
acids in cell membranes. Acrolein also occurs in the environment as a ubiquitous pollutant that is 
generated as a byproduct of overheated organic materials. The half-life of acrolein is estimated to 
be in the order of several hours, which is 100 billion times longer than that of many ROS. As 
such, acrolein is capable of diffusing to and injuring the otherwise healthy tissue.3,46 Acrolein is 
the most potent electrophile among the unsaturated aldehydes. Acrolein-induced membrane 
damage may be an important pathogenic mechanism leading to cell death and functional loss in 
SCI.3,46 Previous studies have demonstrated that acrolein is significantly increased following 
SCI, which is highly toxic to the spinal cord tissue.3,46 As early as 4 h following SCI in vivo, 
acrolein was found to increase and remain elevated for at least 7 days after injury.3,46 Notably, 
acrolein have been found to be elevated in the brain tissue and in the body fluids of patients with 
SCI.3,46 Elevation of acrolein can deplete the cellular antioxidant glutathione as acrolein readily 
reacts with glutathione. This further compromises the endogenous antioxidant defenses.3,46 
Multiple studies also suggested that acrolein may represent a potential marker of oxidative stress 
damage to cellular constituents, especially protein targets in the spinal cord.3,46 
The presence of protein-bound acrolein could be detected by an antibody (mAb5F6) raised 
against the acrolein-modified proteins using immunoblot assay.47,48 To visualized the 
accumulation of acroleinmodified proteins, immunohistochemical staining can be used with the 
same antibody against the acrolein-modified proteins.47,48 
8-Iso-prostaglandin F2α. 8-Iso-prostaglandin F2α is an isoprostane that has been shown to be 
useful for assessing oxidative stress in spinal cord ischemia.49 It is a biologically stable end-
product of the free radical-induced oxidation of arachidonic acid produced from non-
cyclooxygenase and cyclooxygenase peroxidation pathways. It appears in normal plasma and 
urine samples and is elevated by oxidative stress. Determination of 8-iso-prostaglandin F2α has 
been proposed as a reliable index of oxidative stress during SCI.50 
Several different techniques have been used to assay 8-iso-prostaglandin F2α. These include gas 
chromatography-mass spectrometry, enzyme immunoassay and radioimmunoassay. Recently, 
Basu50 has raised an antibody specific for 8-iso-prostaglandin F2α and developed an enzyme-
linked immunosorbent assay for the measurement of 8-iso-prostaglandin F2α in biological fluids. 
In experimental spinal cord ischemia, a significant and immediate increase of 8-iso-prostaglandin 
F2α in plasma at the start and up to 60min, and in the urine at 90–50 min was observed, 
indicating a consequence of oxidative injury.49 Compared with other assays, the greatest 
advantage of this immunoassay is that the level of 8-iso-prostaglandin F2α is sufficient to be 
detected in every normal biological fluid, and the limit of detection is down to 23 pmol l-1. 
Antioxidant-based strategies for intervention of SCI 
The involvement of ROS in the pathogenesis of SCI has prompted extensive studies on the 
neuroprotective effects of various compounds with antioxidative properties in animal models of 
SCI. It is possible that the use of certain antioxidants may slow the progression of spinal cord 
damage. This section begins with a description of Cu,ZnSOD in protecting against SCI followed 
by summarizing the major recent findings on SCI protection by some non-protein compounds 
with antioxidant properties. 
Cu,ZnSOD. ALS is a fatal motor neuron degenerative disease characterized by a loss of motor 
neurons in the central nervous system including spinal cord. Among all of the familial ALS 
patients, 20–30% of them have point mutations in the gene that encodes Cu,ZnSOD.43 Over 100 
different missense substitutions in the 153-amino acid Cu,ZnSOD have been described in 
individuals and kindreds affected by Cu,ZnSOD-linked familial ALS.51 Bowling et al.44 
reported that cytosolic SOD activity, which was primarily Cu,ZnSOD activity, was reduced 
significantly in familial ALS with SOD1 mutations. Therefore, Cu,ZnSOD is likely an important 
therapeutic target that protects neurons from ROS damage after SCI. Utilizing Cu,ZnSOD-
overexpressing transgenic rats and a mild spinal cord compression model to induce selective 
death of ventral horn motor neurons, Sugawara et al.52 reported that overexpression of 
Cu,ZnSOD reduced both the production of superoxide at an early stage after SCI and the 
subsequent ROSmediated death of ventral horn motor neurons, supporting that Cu,ZnSOD is a 
potential therapeutic agent. However, it is important to note the overexpression of antioxidant 
enzymes via genetic approaches is currently not practical for the intervention of human SCI. In 
this context, PEP-1, a 21-residue peptide carrier, has been developed for efficiently delivering 
Cu,ZnSOD fusion protein into cultured neurons and injured spinal cord in vivo.22 Systemic 
administration of the fusion PEP-1-Cu,ZnSOD1 protein protected motor neurons from ROS 
damage and improved recovery after SCI.22 These findings suggest that PEP-1-Cu,ZnSOD may 
represent a new strategy for delivery of antioxidant enzymes for therapeutic intervention of SCI. 
Non-protein compounds with antioxidant properties. Vitamin E: Vitamin E is an excellent 
antioxidant because it is a biological compound that is naturally present in animal and human 
tissues. It can cross intact cell membranes and has a long half-life and good bioavailability. 
Pretreatment with vitamin E has been shown to be protective in animal models of SCI.2,53 Iwasa 
et al. systemically studied the effects of vitamin E on injury of the spinal cord associated with 
ischemia in rats.54,55 The results showed that the motor disturbance induced by SCI was greatly 
reduced and spinal cord blood flow was promptly restored and remained normal after injury in 
the vitamin E-supplemented group. Tariq et al.56 have demonstrated that diabetic animals are 
more susceptible to compressive SCI as compared with nondiabetic animals most likely resulting 
from the higher depletion of vitamin E and glutathione in diabetic rats. Wang et al.57 reported 
that vitamin E feeding attenuated some of the detrimental effects of SCI on sperm functions and 
male accessory glands in rats, supporting a role of ROS-related events in deterioration of SCI. 
Methylprednisolone: Methylprednisolone is a synthetic glucocorticoid steroid with potent anti-
inflammatory activities. Methylprednisolone has been shown to also inhibit lipid peroxidation in 
vitro.2 Compression trauma of the cat spinal cord is known to induce a very rapid alteration in 
the lipid metabolism of cellular membranes leading to the secondary development of tissue ionic 
imbalance, ischemia, edema and inflammation.2 Studies demonstrated that pretreatment of cats 
with methylprednisolone (15–30mg kg-1, i.v.) soon after blunt SCI decreased posttraumatic lipid 
peroxidation as measured by various biochemical indices.23–25 In addition to its ability to 
inhibit lipid peroxidation, methylprednisolone at high dose (30mg kg-1, i.v.) has been shown to 
support energy metabolism, prevent progressive posttraumatic ischemia development, reverse 
intracellular calcium accumulation, ameliorate neurofilament degradation and inhibit membrane 
lipid hydrolysis.2 These actions could lead to an attenuation of posttraumatic neuronal 
degeneration after the injured spinal cord. However, when used at high dosage for extended 
period of time, methylprednisolone causes serious side effects, including weight gain, glaucoma, 
osteoporosis and psychosis. Despite the above adverse effects, methylprednisolone treatment has 
been shown to be beneficial in patients with SCI. 
21-Aminosteroids: 21-Aminosteroids are methylprednisolone derivatives. Compared with 
methylprednisolone, 21-aminosteroids lack the glucocorticoid side effects that limit the clinical 
usefulness of highdose methylprednisolone. The compound U-74006F is one of a series of 21-
aminosteroids, which has been specifically developed for acute treatment of central nervous 
system trauma and ischemia due to its potent inhibition of lipid peroxidation.2,26 U-72099E has 
been shown to be more potent than methylprednisolone in protecting rat brain synaptosomes 
from lipid peroxidation-induced inhibition of 14C-GABA uptake.2,26 In addition, it equaled the 
ability of methylprednisolone to enhance the early neurological recovery of head injured mice.2 
The dose-response characteristics and capability of U-74006F to promote functional recovery in 
cats subjected to compression trauma of the upper lumbar (L-2) spinal cord have also been 
evaluated.58 Results showed that over a 100-fold range of doses, U-74006F has a remarkable 
capacity to promote functional recovery in spinal cord injured cats. The mechanism of protective 
action of U-74006F against SCI is believed to involve an inhibition of oxygen radical-mediated 
lipid peroxidation. In vivo studies have demonstrated that U-74006F can preserve tissue vitamin 
E levels in central nervous system trauma.59 In a manner similar to vitamin E, U-74006F has 
been found to scavenge lipid peroxyl radical thereby inhibiting lipid radical chain reactions.26 
U-74006F also decreased hydroxyl radical formation from Fenton reactions like due to its ability 
to chelate redox-active iron.2 
3H-1,2-dithiole-3-thione: as noted earlier, the central nervous system is particularly vulnerable to 
oxidative stress due to many intrinsic factors. Notably, the central nervous system also has 
relatively low glutathione levels compared with the other organs such as the liver. Because the 
coordinated actions of glutathione and a spectrum of other cellular antioxidative enzymes are 
essential for efficient detoxification of ROS that participate in the pathogenesis of SCI, we 
propose a novel strategy for protective/therapeutic intervention of SCI through coordinated 
upregulation of endogenous antioxidants in the neuronal cells mediated by 3H-1,2-dithiole-3-
thione (D3T). D3T is a constituent of cruciferous vegetables. We have recently reported that 
D3T increases multiple cellular antioxidants including glutathione and NQO1, two crucial 
cellular defenses against oxidative and electrophilic stress in human neuroblastoma cells (SH-
SY5Y), human primary neurons and astrocytes, suggesting that D3Tmediated antioxidant 
induction is not cell-type specific.60–62 In addition, D3T treatment of the neuronal cells also 
results in a marked elevation of glutathione content in the mitochondrial compartment,62 a 
critical intracellular target for oxidative and electrophilic stress.63 It is important to note that the 
D3T upregulated endogenous defenses are accompanied by increased cellular resistance to 
neurocytotoxicity elicited by ROS and several well-known neurotoxins including acrolein, 
suggesting a potential therapeutic value in SCI.60–62 
Table 1. Other major agents shown to be protective against SCI in experimental models 
Agents  Experimental models Results /mechanisms of action  Reference 
Scutellaria baicalensis 
(EESB), a herbal remedies 
in oriental Medicine 
Primary microglial 
cultures and rat model 
following a spinal cord 
contusion injury 
EESB treatment significantly improved 
functional recovery by inhibiting 
inflammation and oxidative stress after 
injury both in vivo and in vitro. 
66 
A novel peptide 
antioxidant (SS-31)  
In vitro and in the G93A 
mouse model of 
amyotrophic lateral 
sclerosis (ALS) 
 Administration of SS-31 in G93A ALS 
mice before the onset of symptoms led to a 
significant increase in survival and 
improvement of motor performance. SS-31-
treated mice showed a decreased cell loss 
and a decrease in immunostaining for 
markers of oxidative stress in the lumbar 
spinal cord.  
67 
Polyethylene glycol 
(PEG), a hydrophilic 
polymer 
Guinea pig SCI model  PEG treatment decreased ROS elevation and 
lipid peroxidation induced by SCI, possible 
through inhibiting superoxide mechanism. 
68 
Edaravone (3-methyl-1-
phenyl-pyrazolin-5-one), a 
newly developed radical 
scavenging agent 
 Murine model of 
incomplete SCI  
Pretreatment with edaravone significantly 
improved motor dysfunction and 
ameliorated tissue damage by scavenging 
ROS, especially in the neurons, after SCI. 
69 
2,4-Dinitrophenol (DNP), 
a mitochondrial 
uncoupling agent 
 Rat model following a 
mild to moderate spinal 
cord contusion injury 
Pretreatment with DNP maintained 
mitochondrial bioenergetics and 
significantly decreased ROS levels, lipid 
peroxidation, and protein carbonyl content 
following SCI. 
70 
Hypericum perforatum, a 
medicinal plant species 
containing many 
polyphenolic compounds 
 An experimental mouse 
model of SCI  
Hypericum perforatum (30mg kg-1 bw) has 
strong anti-inflammatory properties resulting 
in a reduced histological damage, 
polymorphonuclear leukocyte infiltration, 
formation of PAR and nitrotyrosine, STAT-
3 activation, NF-kB activation, and degree 
of apoptosis. 
71 
H-290/51, an antioxidant 
compound  
A rat model of SCI  Treatment with H-290/51 (50mgkg-1, p.o.) 
10 and 30min after SCI markedly attenuated 
c-fos expression and motor dysfunction 
suggesting that this antioxidant is capable of 
attenuating cellular and molecular events 
following trauma. 
72 
Alpha-Phenyl-N-tert-butyl 
Nitrone (PBN), a free 
radical scavenger 
A rat model of severe 
SCI 
 PBN pretreatment attenuates lactic acidosis 
and improves energy metabolism after 
severe SCI suggesting the amelioration of 
radical induced mitochondrial dysfunction. 
73 
Tetramethylpyrazine In a rat model of spinal Treatment with TMP exerted a 74 
(TMP)  cord ischemiareperfusion 
injury  
neuroprotective effect against spinal cord 
ischemia-reperfusion injury.  
Resveratrol, a natural 
phenolic compound 
A rat model of SCI  Resveratrol significantly promotes the 
recovery of rat dorsal neuronal function after 
SCI, and this effect is related to its 
characteristics of antioxidation, anti-
inflammation and anti-apoptosis. 
75 
Resveratrol  A rabbit model of SCI  Prophylactic use of resveratrol reduced 
neurologic injury and provided clinical 
improvement by attenuating the 
inflammatory milieu in the rabbit spinal cord 
ischemia/reperfusion model. 
76 
U74389F, a compound in 
a family of 21-
aminosteroids that inhibit 
lipid peroxidation  
A rat model of SCI  The bolus administration of U74389F one 
hour after injury facilitates the return of the 
spinal cord function as measured by the 
CSEPs in this compression model of acute 
spinal cord trauma. 
77 
Neu2000, a novel NMDA 
antagonist and antioxidant 
 A rat model of moderate 
SCI  
Neu2000 treatment significantly reduced the 
production of mitochondrialfree radicals and 
improved locomotor outcomes that were 
associated with a significant increase in the 
volume of spared spinal cord tissue. 
78 
Quercetin, a flavonol  A rat model of SCI  Quercetin administration results in 
preservation of tissue bridges at the site of 
injury. Treatment success depends on 
frequency of administration and overall 
dose. 
79 
Curcumin, a member of 
the ginger family 
(Zingiberaceae) 
A rat model of SCI  Curcumin inhibited apoptosis and neuron 
loss, quenched astrocyte activation, and 
significantly improved neurologic deficit 7 
days after spinal cord hemisection. 
80 
Caffeic acid phenethyl 
ester (CAPE), a 
component of propolis 
A rat model of SCI  CAPE enhanced the recovery of locomotor 
function and reduced the lesion size while 
suppressing the expression of the mRNAs 
for a pro-inflammatory cytokine. 
81 
Epigallocatechin Gallate 
(EGCG)  
A rat model of SCI  MDA levels were significantly decreased in 
EGCG treatment groups. EGCG 
significantly reduced the percentage of 
lesion area and improved behavioral 
function than the trauma group. 
82 
NAC (N-acetyl-cysteine), 
a precursor to glutathione 
A rabbit mode of spinal 
cord ischemia-
reperfusion (I-R) 
NAC showed protective effects of the spinal 
cord.  
83 
Baicalin (BC), a flavone  A rat model of SCI  The BC therapy (100mgkg-1) dramatically 
decreased the water content of spinal cord 
tissue, the permeability of blood-spinal cord 
barrier, oxidant stress and proinflammatory 
cytokines expression. Also, the treatment 
with BC also significantly improved the 
recovery of limb function. 
84 
Polyethylene glycol (PEG)  A rat model of SCI  Post-SCI administration of PEG decreased 
lesion volume, increased neurofilament-
positive fibers and corticospinal tract fibers 
in the lesion, and did not increase reactive 
gliosis. 
85 
Taurine, a potent 
antioxidant  
A rat model of SCI  Taurine significantly decreased IL-6 and 
MPO levels in a dose-dependent manner and 
significantly reduced the phosphorylation of 
STAT3 and expression of COX-2 after SCI 
compared to controls. 
86 
Alpha-tocopherol  A rat model of SCI  The administration of alpha-tocopherol 
significantly improved the mean motor score 
compared with control group due to its 
antioxidant effect. 
87 
Alpha-tocopherol  In a rat model of spinal 
cord ischemia-
reperfusion Injury 
 Alpha-tocopherol administration improves 
the oxidative stress level and significantly 
prevents the damage caused by spinal cord 
ischemia-reperfusion injury with subsequent 
recovery of both motor and sensory 
functions. 
88 
Methylprednisolone (MP) 
and the nonglucocorticoid 
21-aminosteroid tirilazad 
Acute SCI  Administration of these compounds has been 
demonstrated in the multicenterNASCIS 
clinical trials to produce at least a modest 
improvement inneurological recovery when 
administered within the first 8 hours after 
SCI. 
89 
Curcumin  A rat model of SCI  Curcumin administration increases SOD 
level and significantly prevents the damage 
(decreased MDA level) compared to control 
group indicating that curcumin effectively 
protects the spinal cord tissues against 
oxidative damage. 
90 
Lipoid acid (LA)  In a rat model of spinal 
cord ischemia-
reperfusion injury 
LA pretreatment reduced neurologic injury 
in the rats, most probably by maintaining the 
oxidant/anti-oxidant ion balance during 
spinal cord ischemia. 
91 
High doses of vitamins C 
and E (100mg kg-1 day-1) 
A rat model of SCI  The use of vitamins C and E did not improve 
their neurological performance. However, 
histopathological examination showed that 
the inflammatory response was less intense 
following administration of the combination 
of vitamins C and E. 
92 
Aluminum  A rat model of SCI  Administration of aluminum significantly 
impaired the recovery following SCI. 
Analysis of the results of the biochemical, 
electrophysiological, and histopathological 
studies also confirmed the deleterious effects 
of aluminum on recovery from SCI in rats. 
93 
17beta-estradiol  In a rat model of SCI  17beta-estradiol protects schwann cell (SCs) 
against oxidative stress and improves 
transplanted SC survival. 
94 
Tadalafi  In a rat model of SCI  Tadalafil is beneficial in reducing the effects 
of injury to the spinal cord by increasing 
tissue levels of NO and serum activity of 
SOD. 
95 
Acetyl-L-carnitine (ALC)  In a rat model of SCI  ALC treatment maintains mitochondrial 
bioenergetics following contusionSCI. 
96 
Sulforaphane  A murine model of SCI  Suforaphane decreases MMP-9, TNF-alpha 
expression and vascular permeability 
changes following SCI in mice. 
97 
Deferoxamine  In a rat model of SCI  Deferoxamine reduced the levels of free iron 
and lipid peroxidation, and improved the 
hind limb functional status of rats with SCI. 
98 
Epigallocatechin gallate 
(EGCG)  
In a rat model of SCI  EGCG is effective in protecting rat spinal 
cord from secondary injury by reducing the 
percentage of lesion area and improving 
behavioral function.  
99 
Infliximab  A rabbit I/R model  Infliximab protected the spinal cord against 
injury in a rabbit I/R model with decreased 
level of MDA in the tissue. 
100 
Baicalin (BC)  In a rat model of SCI  BC treatment significantly decreased 
oxidative stress and attenuated the SCI. 
 
Ethyl pyruvate (EP)  A rabbit model of SCI  EP affords a strong protection against the 
transient spinal cord ischemic injury through 
inhibition of HMGB1 release. 
101 
Dantrolene  A rabbit model of SCI  Dantrolene DNT treatment prevented lipid 
peroxidation by SCI, and augmented 
endogenous enzymic or non-enzymic 
antioxidative defense systems. 
102 
Melatonin  A rabbit model of SCI  Melatonin administration reduced the 
incidence of SCI with decreased MDA 
levels and increased glutathione in serum 
and tissue. 
103 
Octreotide and melatonin  In a rat model of SCI  Melatonin was found to be superior to 
octreotide to attenuate the SCI.  
104 
Lecithinized superoxide 
dismutase  
In a rat model of SCI  Lecithinized superoxide dismutase 
suppressed neuronal death through reducing 
oxidative stress. 
105 
Polyunsaturated fatty 
acids.  
In a rat model of SCI Omega-3 PUF was found to be 
neuroprotective and omega-6 PUFAs had a 
damaging effect after SCI in the adult rat. 
106 
Nigella sativa (NS)  In a rat model of SCI  NS treatment is beneficial in spinal cord 
tissue damage through reducing oxidative 
stress. 
107 
MnTBAP  In a rat model of SCI Treatments with the low doses of MnTBAP 
provide sustained neuroprotection by 
preventing oxidative stress. 
108 
Ginkgo leaf extracts  In a rat model of SCI  Ginkgo leaf extracts afford a strong 
protection against SCI through reducing 
lipid peroxidation injury and inhibiting 
apoptosis. 
109 
Resveratrol and 
methylprednisolone (MP)  
In a rat model of SCI  Resveratrol treatment revealed better 
biochemical recovery in the acute stage of 
trauma than MP treatment and combinations 
promise better results as each drug has a 
different anti-oxidative mechanism of action. 
110 
Ebselen  In a rat model of SCI  Ebselen treatment decreased tissue MDA 
level and prevented inhibition of the 
enzymes SOD, GSH-Px and CAT in the 
tissues induced by SCI. 
111 
Glutathione monoethyl 
ester (GSHE)  
In a rat model of SCI  GSHE treatment improved functional 
outcome and red nuclei neuron survival of 
SCI. 
112 
Polyethylene glycol 
(PEG).  
In a guinea pig model of 
SCI  
PEG exerted its neuroprotective effect 
through direct interaction with mitochondria 
113 
and reducing oxidative stress. 
Resveratrol  A rabbit I/R model  Resveratrol-induced neuroprotection is 
mediated by its antioxidant and NO 
promoting properties. 
114 
Melatonin, and 
oxytetracycline  
In a rat model of SCI  Melatonin and oxytetracycline are effective 
in preventing lipid peroxidation in SCI. 
115 
H-290/51  In a rat model of SCI  The antioxidant compound H-
290151markedly attenuated the 
traumainduced oxidative stress. 
116 
Glutathione  In a rat model of SCI  Glutathione significantly attenuated LPO-
mediated damage in acute phase SCI. 
117 
BDNF  In a rat model of SCI  Infusion of BDNF inhibited the acute down-
regulation of CuZnSOD expression. 
118 
Methylprednisolone (MP), 
tirilazad mesylate (TM) 
and vitamin E 
In a rat model of SCI  Treatments of MP, TM and vitamin E 
afforded a protective effect against SCI in 
rats by their antioxidant effects. 
119 
Methylprednisolone 
sodium succinate (MPSS). 
In a rat model of SCI  MPSS administration significantly decreased 
the level of lipid peroxidation and protected 
spinal cord ultrastructure following SCI. 
120 
Caffeic acid phenethyl 
ester (CAPE)  
A rabbit I/R model  CAPE protected the spinal cord from 
ischemia-reperfusion injury through its 
antioxidant effect. 
121 
Alpha-tocopherol  In a rat model of SCI  Long term administration of alpha-
tocopherol decreased lipid peroxidation 
following acute spinal cord trauma. 
122 
 
Other compounds: several epidemiological studies have demonstrated that increased 
consumption of antioxidant-rich fruits and vegetables is associated with reduced risk of ischemic 
stroke, dementia and SCI.64,65 In this context, identification and study of the biologically active 
compounds may be of importance for developing strategies to inhibit, retard or reverse the 
pathophysiological processes underlying SCI. Beside the aforementioned agents with antioxidant 
properties for treating SCI, there are numerous dietary and botanical natural compounds in fruits, 
vegetable and plants (such as green tea compounds and herbal remedies) being actively 
investigated for their potential benefits in SCI. These include carotenoids and phenolic 
compounds. Carotenoids are ubiquitous in the plant kingdom, and as many as 1000 naturally 
occurring variants have been identified. Plant phenols are antioxidants by virtue of the hydrogen 
donating properties of the phenolic hydroxyl groups, and over 8000 plant phenols have been 
isolated. Dietary plants rich in these compounds include broccoli, brussel sprouts, cabbage, kale, 
cauliflower, carrots, onions, tomatoes, spinach, garlic and some herbal medicines. Additionally, 
some compounds found in these plants may improve the endogenous antioxidant defense through 
induction of antioxidant enzymes. 
Table 1 lists some bioactive compounds derived from different sources showing benefits in 
protecting against oxidative stress underlying SCI. These compounds have been shown to 
suppress lipid peroxidation due to their antioxidant properties including scavenging ROS, 
chelating redox-active metal ions and inhibiting xanthine oxidase. However, the exact cell 
signaling pathways activated by these natural bioactive agents are still not clear, and each 
compound may act differently in different cells. Studies have suggested that the protective role 
of these compounds against oxidative stress damage is mediated, at least partially, by effects on 
signaling molecules including extracellular signal-regulated kinase, nuclear factor kB and 
Nrf2.18,27–31 Nrf2 signaling appears to has a central role in regulating the induction of 
antioxidants by phenolic compounds.18,27–31 
CONCLUSION 
The central nervous system, including spinal cord is highly susceptible to free-radical-mediated 
damage due to its high lipid content and active oxygen metabolism. It has been demonstrated that 
ROS and oxidative stress have a significant role in the pathophysiology of SCI and are a 
hallmark of the secondary injury underlying SCI in animal models. Thus, alleviating oxidative 
stress of secondary injury process may represent an effective strategy for therapeutic intervention 
of SCI. In this regard, continued studies on bioactive compounds with ROSscavenging capacity 
may lead to the development of effective antioxidant- based modalities for treating SCI in human 
subjects. 
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